Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CCX354-C in rheumatoid arthritis with partial methotrexate response
ISRCTN67054656Phase 2Completed
- Sponsor
- ChemoCentryx
- Start
- Sep 2010
- Modality
- Small Molecules
01
Overview
Phase 2, randomised trial of CCX354 in rheumatoid arthritis (RA) (3 arms), sponsored by ChemoCentryx. Primary endpoint: Incidence of adverse events. Started Sep 2010; status: completed.
02
Drugs
CCX354
03
Conditions
rheumatoid arthritis (RA)
Beyond the preview
Go deeper on ISRCTN67054656.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ISRCTN67054656.